Theralase(R) Grants Stock Options
TORONTO, ON / ACCESSWIRE / September 21, 2023 / Theralase Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic …
Weiterlesen »